Magnesium Testing in Athletes: Why Serum Magnesium Misses the Deficit, When to Order RBC Magnesium, and How to Document the Workup in the Sports RD SOAP

A collegiate distance runner is referred to the sports RD with a six-week complaint of nocturnal calf cramps, mid-week training-quality drops, and a resting heart rate that has crept 6 bpm above her preseason baseline. Her primary-care panel returned last month with a serum magnesium of 1.9 mg/dL — squarely inside the reference range of 1.7 to 2.2 mg/dL. Her coach has already added a magnesium citrate supplement based on a podcast, and the athlete wants to know whether she needs it. The referring physician has written no nutrition recommendations because the serum number was normal.

This is one of the most common interpretive errors in the sports dietetics workup. Serum magnesium is not a screening test for functional magnesium adequacy in athletes. It is a homeostatic snapshot of a compartment that holds roughly one percent of total body magnesium, is aggressively defended by parathyroid hormone and renal reabsorption, and can sit inside the reference range on top of a real intracellular deficit for months before it moves. Reading a normal serum magnesium as evidence that the athlete does not need a magnesium workup is the equivalent of reading a normal fasting glucose as evidence that the athlete does not have insulin resistance — the compartment being measured is not where the physiology is happening.

This post is the RBC-magnesium-versus-serum-magnesium interpretation guide for the sports RD, the training-load and symptom triggers that justify escalating from serum to RBC, the diet-recall protocol that has to precede any supplement recommendation, the four supplemental forms with their dose-response and GI-tolerance profiles, the drug-nutrient interactions that shift the workup, and the SOAP-note documentation that lets the referring physician, the athletic trainer, and the strength coach act on the finding without a second consult.

Why Serum Magnesium Underreports the Deficit

Total body magnesium in a 70-kg adult is approximately 24 grams. Roughly 60 percent sits in bone, 27 percent in muscle, 6 to 7 percent in other soft tissue, and less than 1 percent in serum and interstitial fluid combined. The circulating pool that a standard serum magnesium measures is the smallest compartment and the most tightly regulated.

When dietary intake or intestinal absorption drops, the body protects serum magnesium by pulling from bone and by increasing renal reabsorption in the loop of Henle and distal tubule. Parathyroid hormone, calcitriol, and renal magnesium transporters coordinate the defense. The result is that serum magnesium can remain in range while total body magnesium is falling — a state sometimes described in the literature as chronic latent magnesium deficiency. Population-level estimates put the prevalence of subclinical magnesium inadequacy in adults at 15 to 20 percent, and in athletic populations with higher sweat losses and training-induced turnover the number runs higher still.

The corollary for the workup is that a normal serum magnesium in a symptomatic athlete does not close the differential. It only tells the RD that the homeostatic defense is still working. A symptomatic athlete with a normal serum magnesium and plausible risk factors is a candidate for a deeper look.

The RBC Magnesium Escalation

Red blood cell magnesium (RBC-Mg, sometimes ordered as erythrocyte magnesium) is the widely available second-tier test. RBCs concentrate magnesium at roughly three times serum levels and turn over across a 120-day window, so the RBC compartment integrates magnesium status across the preceding several months rather than reporting the current homeostatic snapshot.

The reference range varies by lab and reporting units, but a common set is 4.2 to 6.8 mg/dL (or approximately 1.65 to 2.65 mmol/L). Values in the lower quartile of the reference range in a symptomatic athlete carry meaningful interpretive weight — this is a compartment that lags before it corrects, so an athlete trending toward the floor of the range often benefits from intervention even before the value drops below the cutoff.

RBC magnesium is not a perfect gold standard. The intracellular magnesium relevant to neuromuscular function sits in skeletal muscle, not in erythrocytes, and the correlation between RBC and muscle-magnesium is imperfect. Ionized magnesium (the biologically active fraction of serum) and magnesium-loading tests (the 24-hour urinary retention protocol, which measures how much of an intravenous magnesium load the kidney retains) both exist, but availability outside academic centers is limited and the loading test is not practical for outpatient sports nutrition workups. For most RDs practicing outside of academic sports medicine, the RBC magnesium is the accessible best-available second-tier test.

The Escalation Triggers

Do not order RBC magnesium on every athlete. The screening question is: does the symptom profile plus the training and dietary context make a functional magnesium deficit plausible enough to justify the escalation? The triggers I use to move from serum-only to RBC:

• Neuromuscular symptoms. Nocturnal cramping, fasciculations, twitchy calf or eyelid, unexplained increase in perceived training strain, exercise-associated cramping that does not respond to sodium and hydration adjustments.
• Autonomic drift. Resting heart rate creeping upward across weeks without a corresponding training-load explanation, HRV trending down, sleep quality degrading. Magnesium participates in parasympathetic tone and its inadequacy shows here first in a subset of athletes.
• High sweat-rate training environments. Long-duration endurance athletes, hot-weather sport athletes, combat athletes in weight-cut cycles. Sweat magnesium losses are small in absolute terms but non-trivial across a full training block.
• Documented low intake. A three-day diet recall showing intake below the 320 mg/day RDA for women or 420 mg/day for men, especially against a Mediterranean-diet or plant-forward profile that overreports magnesium relative to whole-food-based tracking.
• PPI or diuretic exposure. Proton-pump inhibitors used chronically cause meaningful magnesium losses; loop and thiazide diuretics increase renal excretion; both are common in the referred-athlete population and both shift the workup.
• Symptomatic athlete with normal serum magnesium. The classic case — the athlete whose primary-care panel has already returned in-range but whose clinical picture has not resolved.

An asymptomatic athlete with unremarkable training-load context and adequate diet-recall intake does not need RBC magnesium ordered. Screen with intake and symptoms; escalate only when the picture warrants it.

The Diet-Recall Step That Has to Come First

Before ordering additional labs or recommending supplementation, run a structured three-day diet recall and quantify magnesium intake against the RDA. The RD-conducted recall should capture:

• Total daily magnesium intake in mg, cross-referenced to a food-composition database that includes trace mineral values (USDA FoodData Central is the accessible standard; be aware that magnesium values in the database can be missing or estimated for many entries).
• The proportion of intake from whole-food sources versus enriched-grain sources versus fortified products. Enriched-grain magnesium has lower bioavailability than the phytate-bound magnesium in whole grains would suggest, but the whole picture matters more than any single food.
• Calcium-to-magnesium ratio in the intake. A ratio above roughly 4:1 (calcium in mg to magnesium in mg) can compete with magnesium at the intestinal-transport level in some individuals; ratios in the 2:1 to 3:1 range are less likely to interfere.
• Alcohol intake. Chronic alcohol intake at more than 2 drinks per day increases renal magnesium excretion and is one of the most under-appreciated dietary drivers of latent deficiency in the general population.

A low intake on recall in a symptomatic athlete with plausible risk factors is often enough to justify a trial of dietary intervention plus supplementation without waiting for the RBC magnesium to return. A high intake on recall in a symptomatic athlete points toward absorption or losses rather than intake and shifts the workup toward the drug-nutrient interaction review.

The Four Supplemental Forms and Their Profiles

Magnesium supplements are not interchangeable. The four forms most commonly encountered in the athlete population, with their functional profiles:

Magnesium oxide. The most common form on retail shelves because it delivers the highest elemental magnesium per gram (roughly 60 percent). Bioavailability is the lowest of the common forms — often cited as 4 to 5 percent absorbed — and the unabsorbed fraction has a strong osmotic laxative effect. Useful as a low-cost laxative; a weak choice for correcting a functional deficit.

Magnesium citrate. Modest elemental content (about 11 percent), meaningfully better absorbed than oxide (some studies report 25 to 30 percent), and still carries a laxative effect at higher doses. A reasonable first-line choice for athletes with mild-to-moderate inadequacy who tolerate the GI profile.

Magnesium glycinate (bisglycinate). Chelated form; elemental content around 14 percent. Well tolerated at higher doses because the glycine chelation reduces the osmotic laxative effect that limits oxide and citrate. Preferred form for athletes who need higher supplemental doses without GI turnover, and the form I recommend most often in symptomatic sleep or nocturnal-cramping presentations because glycine itself has downstream sleep-supportive effects.

Magnesium malate. Elemental content around 11 percent. Marketed for muscular fatigue on the theory that malate participates in the Krebs cycle, though the practical case for malate over glycinate for most athletes is thin. A reasonable option for athletes who report fatigue-dominant symptoms and tolerate it well.

Doses in the athlete population typically range from 200 to 400 mg elemental magnesium per day, split into two doses to minimize the laxative effect and improve tolerance. Start at the low end and titrate over 2 to 3 weeks. Above 400 mg per day from supplementation, escalate the monitoring — serum and RBC in another 8 to 12 weeks, plus a check on renal function if not already documented.

Do not recommend supplementation above the Tolerable Upper Intake Level (350 mg from supplemental sources per day in most guideline frameworks) in athletes with any documented renal impairment. Magnesium clearance is renal; impaired clearance plus supplementation is the classic path to iatrogenic hypermagnesemia.

Drug-Nutrient Interactions to Screen

The supplement reconciliation and medication review has to precede the treatment plan. Interactions that shift the magnesium workup:

• Proton-pump inhibitors (omeprazole, esomeprazole, pantoprazole) at more than 12 months of continuous use are associated with meaningful hypomagnesemia in a subset of users. The FDA has a public communication on this. Athletes on chronic PPI for reflux who present with magnesium symptoms need the PPI-mediated malabsorption on the differential.
• Loop and thiazide diuretics (furosemide, hydrochlorothiazide) increase renal magnesium excretion. Uncommon in a healthy competitive athlete but present in the general referred population and in some tactical-athlete cohorts on antihypertensive therapy.
• Quinolone and tetracycline antibiotics chelate with magnesium and reduce absorption of both the drug and the mineral if co-administered. Spacing by 2 to 4 hours resolves it during a short course; a longer regimen may warrant separate discussion with the prescriber.
• High-dose zinc supplementation (above roughly 40 mg elemental zinc per day) competes with magnesium absorption at the intestinal-transporter level in some individuals.

None of these are reasons to withhold treatment. They are reasons the SOAP note must document the medication and supplement inventory and the timing plan for administration.

The SOAP Documentation That Closes the Loop

The workup is only useful to the referring physician, the athletic trainer, and the strength coach if the SOAP note captures the interpretation and the plan in the language those readers need. The magnesium-workup SOAP structure:

Subjective. Presenting symptoms with duration and severity, self-reported training-quality change, sleep quality, cramping pattern (nocturnal versus exertional), current supplement stack including brand and dose, medication list including OTC and PPI, alcohol intake, three-day diet-recall summary with quantified magnesium intake against RDA.

Objective. Serum magnesium value and reference range with date, RBC magnesium value if ordered, resting heart rate trend across preceding weeks if available, HRV trend if the athlete uses a wearable, sweat-rate estimate if endurance context, body mass and body-composition data if relevant to dosing.

Assessment. The interpretive line — the sentence the referring physician will read first. Example: "Symptomatic magnesium inadequacy despite in-range serum magnesium (1.9 mg/dL); RBC magnesium in the lower quartile at 4.4 mg/dL; three-day recall intake at 240 mg/day (75 percent of RDA); pattern consistent with chronic latent magnesium deficiency."

Plan. Dietary intervention (specific whole-food targets, quantified), supplemental intervention (form, elemental dose, split, timing relative to training and to any interacting medication), reassessment window (typically 8 to 12 weeks for a repeat symptom check plus optional RBC recheck), red-flag return criteria that route the athlete back to the referring physician (new symptoms, no symptom improvement at 12 weeks, any change in renal function labs).

The assessment-and-plan section is what makes the note useful to the interdisciplinary team. A SOAP note that documents the intake and defers the interpretation to the reader is not a completed workup.

The Reassessment Window

Repeat testing at 8 to 12 weeks is the practical interval. Symptom-level improvement often precedes lab-level movement; a symptomatic athlete who reports resolution of nocturnal cramping, return of training-quality baseline, and normalization of resting heart rate at 6 to 8 weeks does not necessarily need the RBC magnesium rechecked at that visit — the clinical picture is the primary endpoint. Recheck labs at 12 weeks or on the next scheduled panel to document the trend.

An athlete whose symptoms have not moved at 8 weeks on adequate dietary intake and supplementation is a candidate for further workup — the differential broadens to include other electrolyte disturbances (calcium, potassium, phosphorus), thyroid function, iron status if not already screened, and the RED-S evaluation if the training-load and dietary context suggests low energy availability. Magnesium was the first-pass hypothesis; a null result at 8 weeks means the hypothesis is not carrying the symptoms and the RD needs to widen the read.

Documenting the Workup in Calsanova

The magnesium workup is a good example of the multi-visit sports RD workflow that the SOAP-note structure has to hold across time. The initial visit documents the intake, the interpretation, and the plan. The reassessment visit documents the trajectory. The interdisciplinary handoff — to the referring physician, to the athletic trainer, to the strength coach — happens across those two visits, and the reader on the receiving end needs a clean, structured note that captures the plan and the trigger points for escalation back.

Calsanova's SOAP-note templates and structured intake fields are built for this workflow. If you are running sports nutrition workups in a paper-and-PDF workflow and losing time to note-formatting instead of interpretation, the platform pays back the setup investment inside the first month of practice. [Start a Calsanova sports dietitian account](/signup?role=dietitian) to see the workup templates, the structured lab-value fields, and the interdisciplinary handoff formats built for the sports RD.